| Literature DB >> 34939347 |
Long-Jun Shu1, Ji-Yuan Zhang1.
Abstract
OBJECTIVES: To investigate the effect of Jintiange capsule on acute bone atrophy (vertebral height, Cobb's angle, bone mineral density, and visual analog score (VAS) in patients with osteoporotic vertebral compression fracture.Entities:
Keywords: Anti-osteoporosis drug; Jintiange capsule; Osteoporotic vertebral compression indexes
Mesh:
Substances:
Year: 2021 PMID: 34939347 PMCID: PMC8867413 DOI: 10.1111/os.13121
Source DB: PubMed Journal: Orthop Surg ISSN: 1757-7853 Impact factor: 2.279
Fig. 1The illustrative diagram of the study design and the information about the participants. The Figure shows the number of patient recruited to the study, study design, and demographic data.
Fig. 2The Figure illustrates the overall surgical procedure and therapeutic intervention.
Comparison of the total effective rate between the two groups (n = 53)
| Groups | Completely effective (%) | Effective (%) | Non‐effective (%) | Total effective rate (%) |
|---|---|---|---|---|
| Control | 20.8 | 47.2 | 32.1 | 67.9 |
| Study | 35.8 | 54.7 | 9.4 | 90.6 |
| χ2 | 4.610 | |||
|
| <0.043 | |||
| Multivariate analysis | 0.95 (0.92 to 1.01) | |||
Comparison of vertebral imaging indexes between the two groups (n = 53)
| Groups | Vertebral height (mm) | Cobb's angle (°) | Bone mineral density (g/cm) | |||
|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||||
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
| Control | 13.7 ± 1.5 | 24.0 ± 1.4 | 25.2 ± 3.2 | 14.0 ± 1.6 | 0.33 ± 0.07 | 0.33 ± 0.05 |
| Study | 13.9 ± 1.3 | 30.1 ± 1.7 | 25.4 ± 3.3 | 8.5 ± 1.2 | 0.34 ± 0.08 | 0.37 ± 0.10 |
|
| 1.301 | 11.527 | 1.935 | 12.201 | 1.437 | 10.008 |
|
| >0.034 | >0.047 | >0.029 | |||
| Multivariate analysis | 0.57 | 0.94 | 0.64 | 0.97 | 0.69 | 0.98 |
|
| (0.14 to 3.21) | (0.94 to 1.03) | (0.34 to 1.41) | (0.93 to 1.02) | (0.12 to 3.15) | (0.43 to 2.15) |
Comparison of the VAS score between the two groups (n = 53, mean ± SD)
| Groups | Before treatment | 1 month after treatment | 3 months after treatment |
|---|---|---|---|
| Control | 8.4 ± 2.9 | 4.2 ± 1.3 | 2.0 ± 0.9 |
| Study | 8.5 ± 2.8 | 3.4 ± 1.0 | 0.5 ± 0.3 |
|
| 1.638 | 10.819 | 10.116 |
|
| >0.038 | <0.042 | <0.047 |
| Multivariate analysis | 0.81 | 0.97 | 0.94 |
|
| (0.19 to 3.12) | (0.94 to 1.01) | (0.91 to 1.02) |
Comparison of the Oswestry score between the two groups (n = 53) (mean ± SD)
| Groups | Before treatment | 1 month after treatment | 3 months after treatment |
|---|---|---|---|
| Control | 69.8 ± 8.1 | 25.0 ± 2.3 | 15.1 ± 2.1 |
| Study | 68.6 ± 7.8 | 13.4 ± 2.1 | 6.8 ± 1.0 |
|
| 2.001 | 12.546 | 12.130 |
|
| >0.035 | <0.038 | <0.032 |
| Multivariate analysis | 0.76 | 0.96 | 0.98 |
|
| (0.23 to 3.40) | (0.93 to 1.02) | (0.49 to 2.18) |
The subgroup analysis of the control and study groups
| Control group | Study group | ||||
|---|---|---|---|---|---|
| Subgroups | Total | Total |
| ||
| Age (years) | |||||
| 61–68 | 25/53 | 25 | 21/53 | 21 | 0.84 (0.54, 1.10) |
| 69–75 | 28/53 | 28 | 32/53 | 32 | 0.79 (0.64, 1.3) |
| Male | 22/53 | 22 | 24/53 | 24 | 0.82 (0.67, 1.09) |
| Female | 31/53 | 31 | 29/53 | 29 | 1.34 (0.72, 2.17) |
| Thoracic fracture | 17/53 | 17 | 14/53 | 14 | 0.89 (0.51, 1.72) |
| Lumber fracture | 36/53 | 36 | 39/53 | 39 | 0.73 (0.56, 1.86) |